Cargando…
Targeted Genome Engineering to Control VEGF Expression in Human Umbilical Cord Blood‐Derived Mesenchymal Stem Cells: Potential Implications for the Treatment of Myocardial Infarction
Human umbilical cord blood‐derived mesenchymal stem cells (hUCB‐MSCs) exhibit potency for the regeneration of infarcted hearts. Vascular endothelial growth factor (VEGF) is capable of inducing angiogenesis and can boost stem cell‐based therapeutic effects. However, high levels of VEGF can cause abno...
Autores principales: | Cho, Hyun‐Min, Kim, Pyung‐Hwan, Chang, Hyun‐Kyung, Shen, Yi‐ming, Bonsra, Kwaku, Kang, Byung‐Jae, Yum, Soo‐Young, Kim, Joo‐Hyun, Lee, So‐Yeong, Choi, Min‐cheol, Kim, Hyongbum (Henry), Jang, Goo, Cho, Je‐Yoel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442764/ https://www.ncbi.nlm.nih.gov/pubmed/28186692 http://dx.doi.org/10.1002/sctm.16-0114 |
Ejemplares similares
-
Inducible HGF-secreting Human Umbilical Cord Blood-derived MSCs Produced via TALEN-mediated Genome Editing Promoted Angiogenesis
por: Chang, Hyun-Kyung, et al.
Publicado: (2016) -
Coronary stents with inducible VEGF/HGF-secreting UCB-MSCs reduced restenosis and increased re-endothelialization in a swine model
por: Chang, Hyun-Kyung, et al.
Publicado: (2018) -
Stanniocalcin 2 enhances mesenchymal stem cell survival by suppressing oxidative stress
por: Kim, Pyung-Hwan, et al.
Publicado: (2015) -
Umbilical Cord Blood Therapy Potentiated with Erythropoietin for Children with Cerebral Palsy: A Double-blind, Randomized, Placebo-Controlled Trial
por: Min, Kyunghoon, et al.
Publicado: (2013) -
Myocardial tissue engineering using electrospun nanofiber composites
por: Kim, Pyung-Hwan, et al.
Publicado: (2016)